Harnessing peak transmission around symptom onset for non-pharmaceutical intervention and containment of the COVID-19 pandemic

Author:

Tian LiangORCID,Li XuefeiORCID,Qi FeiORCID,Tang Qian-YuanORCID,Tang ViolaORCID,Liu JiangORCID,Li ZhiyuanORCID,Cheng XingyeORCID,Li Xuanxuan,Shi YingchenORCID,Liu HaiguangORCID,Tang Lei-HanORCID

Abstract

AbstractWithin a short period of time, COVID-19 grew into a world-wide pandemic. Transmission by pre-symptomatic and asymptomatic viral carriers rendered intervention and containment of the disease extremely challenging. Based on reported infection case studies, we construct an epidemiological model that focuses on transmission around the symptom onset. The model is calibrated against incubation period and pairwise transmission statistics during the initial outbreaks of the pandemic outside Wuhan with minimal non-pharmaceutical interventions. Mathematical treatment of the model yields explicit expressions for the size of latent and pre-symptomatic subpopulations during the exponential growth phase, with the local epidemic growth rate as input. We then explore reduction of the basic reproduction number R0 through specific transmission control measures such as contact tracing, testing, social distancing, wearing masks and sheltering in place. When these measures are implemented in combination, their effects on R0 multiply. We also compare our model behaviour to the first wave of the COVID-19 spreading in various affected regions and highlight generic and less generic features of the pandemic development.

Funder

National Natural Science Foundation of China

Research Grants Council, University Grants Committee

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Reference48 articles.

1. World Health Organization. Coronavirus Disease 2019 (COVID-19) Situation Report-71 (World Health Organization, accessed 31 March 2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200331-sitrep-71-covid-19.pdf?sfvrsn=4360e92b_8.

2. Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020).

3. World Health Organization. Coronavirus disease (COVID-19) Weekly Epidemiological Update-15 December 2020 https://www.who.int/publications/m/item/weekly-epidemiological-update---15-december-2020.

4. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020 (World Health Organization, accessed 13 March 2020); https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.

5. Anderson, R. M. et al. How will country-based mitigation measures influence the course of the COVID- 19 epidemic? Lancet 395, 931–934 (2020).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3